老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Reviva Pharmaceuticals Holdings, Inc.

0.7416
-0.0422-5.38%
盤前：0.80000.0584+7.87%07:12 EDT
成交量：42.23萬
成交額：31.79萬
市值：943.83萬
市盈率：-0.08
高：0.8002
開：0.8000
低：0.7228
收：0.7838
52周最高：23.20
52周最低：0.6697
股本：1,272.70萬
流通股本：1,255.13萬
量比：0.42
換手率：3.36%
股息：- -
股息率：- -
每股收益(TTM):-8.8000
每股收益(LYR):-18.0520
淨資產收益率：-916.17%
總資產收益率：-130.48%
市淨率：2.07
市盈率(LYR):-0.04

資料載入中...

總覽公司新聞資訊公告
2021/08/16

重要事件披露

8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/06/14

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/03

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/25

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/25

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/19

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/17

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

重要事件披露

8-K - Current report
2021/05/10

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/07

重要事件披露

8-K - Current report
2021/05/07

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/04/19

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/04/15

重要事件披露

8-K - Current report
2021/03/24

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/22

重要事件披露

8-K - Current report
2021/03/22

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
更多